Ecenofloxacin
Alternative Names: CFC-222Latest Information Update: 30 Aug 2007
At a glance
- Originator CJ Corporation
- Class Fluoroquinolones; Small molecules
- Mechanism of Action Type II DNA topoisomerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Bacterial infections